Browse Biological products industry topic

Laws, regulations and rules subtopic

Articles 1-31 out of 31 article(s) Title Author Type Date Words Life Sciences Collaborations ─ Recent Amendments To The BIA And The CCAA And The Use Of Bankruptcy Remote Entities. Armitage, Paul Law overview Dec 6, 2009 1608 Biosimilars In Canada: New Draft Guidelines From Health Canada. Reguly, Teresa Law overview Jul 22, 2009 2426 ENZO BIOCHEM REPORTS RECORD FISCAL 2009 FIRST QUARTER REVENUE. Financial report Jan 1, 2009 1216 Enzo Biochem Reports Operating Results for Fiscal 2009 First Quarter. Financial report Dec 10, 2008 1546 NAD supports specific Polyphenolics claims. Brief article Dec 1, 2008 138 Enzo Biochem Reports Second Quarter and Six-Month Results. Financial report Mar 11, 2008 1503 Cyclacel's David Glover to Present at New York Academy of Sciences Symposium. Mar 4, 2008 780 Committee opposes use of Avastin for breast cancer. Dec 17, 2007 527 Enzo Biochem Reports 2008 Fiscal First Quarter Results. Financial report Dec 10, 2007 1023 Extension Of Manufacturers' Product Liability Exposure After 10-Year Cut-Off Period. Nov 29, 2007 2632 Enzo Reports Improved Fourth Quarter and Fiscal 2007 Results. Financial report Oct 15, 2007 1800 Enzo Biochem Reports Third Quarter Results. Financial report Jun 11, 2007 1467 FDA asks Genentech to strengthen label warning for Xolair. Feb 26, 2007 372 Government. Dec 31, 2006 141 Exceptions To The Usual Routes For Applying For Marketing Authorisations. Wray, Anna Nov 2, 2006 1748 Fiscal 2007 Defense Appropriations Bill Dedicates $2.6 Million to Ongoing Development of AVANT's Oral Anthrax/Plague Combination Vaccine. Oct 2, 2006 896 2006 Trends In Life Sciences Partnering, Collaborations And Strategic Alliances. Sep 28, 2006 2315 DOR BioPharma Provides Financial Guidance and Update on European Regulatory Plans for orBec(R). Feb 8, 2006 1383 Chiron Announces Termination of SEC Investigation. Feb 7, 2006 147 Agencies will "buy biobased" in new USDA program. Brief Article Jan 21, 2005 233 A Prescription for Follow-on Biologics? Jun 16, 2004 2714 Genetically modified crops in Africa: hope, hype and hubris. Ashton, Glenn Mar 22, 2004 1750 Fractionator gets 25-item 483 for process validation, OOS, failure investigations. Sami, Tamra Aug 1, 2003 755 CancerVax treatment goes skin deep: firm's melanoma vaccine appears to be back on track. Webb, Marion May 19, 2003 1376 FDA requires barcodes on drugs and blood products. (News). Brief Article Apr 1, 2003 57 EIR Denials. Brief Article Oct 1, 1999 212 Validation issues consume Team Biologics inspection. Jul 1, 1999 1231 Biotech drug dating becomes FDA issue; some firms lack data. Williams, Deborah Brief Article Jun 1, 1999 739 No warning letter issued despite 31-item IVD 483. Sep 1, 1998 716 More second-guessing seen on product changes : Primarily in biologics, also devices. Brief Article Nov 1, 1997 621 Audit notice, 483 notations not in store for biologics; 510(k) inspections to wane. Brief Article Oct 1, 1997 320